Medicinal products authorised in accordance with Article 14, para. 1, letter abis-ter HMG are based on a foreign reference product for which Swissmedic does not have complete documentation with regard to efficacy and safety. A condition for a Swiss reference medicinal product is that it has been authorised by Swissmedic based on a complete dossier. For this reason, Article 14 products cannot be used as reference medicinal products for further known APIs or authorisation extensions.
Dr. Katharina Oehler
Scientific and Managing Director
Send email